(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 17.48 | 14.51 | 20.47 | 61.36 | 65.28 | -6.00 | 61.36 | 65.28 | -6.00 |
| Other Income | 1.74 | 0.76 | 128.95 | 4.84 | 2.98 | 62.42 | 4.84 | 2.98 | 62.42 |
| PBIDT | 2.65 | 1.74 | 52.30 | 8.91 | 7.94 | 12.22 | 8.91 | 7.94 | 12.22 |
| Interest | 0.11 | 0.16 | -31.25 | 0.47 | 0.42 | 11.90 | 0.47 | 0.42 | 11.90 |
| PBDT | 2.54 | 1.58 | 60.76 | 8.44 | 7.52 | 12.23 | 8.44 | 7.52 | 12.23 |
| Depreciation | 0.39 | 0.35 | 11.43 | 1.56 | 1.31 | 19.08 | 1.56 | 1.31 | 19.08 |
| PBT | 2.15 | 1.23 | 74.80 | 6.88 | 6.21 | 10.79 | 6.88 | 6.21 | 10.79 |
| TAX | 0.45 | -0.27 | -266.67 | 1.75 | 1.23 | 42.28 | 1.75 | 1.23 | 42.28 |
| Deferred Tax | -0.15 | -0.52 | -71.15 | -0.15 | -0.52 | -71.15 | -0.15 | -0.52 | -71.15 |
| PAT | 1.70 | 1.50 | 13.33 | 5.13 | 4.98 | 3.01 | 5.13 | 4.98 | 3.01 |
| Equity | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 | 25.19 | 25.19 | 0.00 |
| PBIDTM(%) | 15.16 | 11.99 | 26.42 | 14.52 | 12.16 | 19.39 | 14.52 | 12.16 | 19.39 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1820.75 |
| Dr. Reddys Lab | 1270.95 |
| Cipla | 1333.55 |
| Zydus Lifesciences | 911.85 |
| Lupin | 2343.40 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: